Tenet Healthcare posts strong Q3 2026 results and lifts full‑year guidance

Tenet Healthcare reported third‑quarter 2026 adjusted earnings per share of $6.64 and revenue of $5.63 billion, beating expectations. The company raised its full‑year 2026 adjusted EBITDA outlook to $5.05 billion‑$5.20 billion and its adjusted earnings per share guidance to $22.05‑$23.01. Management highlighted continued margin expansion and the impact of Conifer transition items on results.

The higher guidance suggests stronger profitability for the rest of 2026, which could support the stock price and influence investor expectations, according to the company’s outlook.

  • 1Q3 2026 adjusted EPS was $6.64, beating estimates by $1.97.
  • 2Q3 2026 revenue was $5.63 billion, up 6.5% year‑over‑year.
  • 3Full‑year 2026 adjusted EBITDA guidance was raised to $5.05 billion‑$5.20 billion.
  • 4Full‑year 2026 adjusted EPS guidance was set at $22.05‑$23.01 per share.
  • 5Shares were unchanged at $268.50 in pre‑market trading after the release.
  • 6CEO Saumya Sutaria noted an 80% increase in adjusted diluted EPS to $6.64.

Sources